Zerodol 100 mg Tablet

Zerodol 100 mg Tablet is a pain-relieving medicine with Aceclofenac (100mg) and Tizanidine (2mg) as an active ingredient. It is prescribed to treat pain & inflammation in conditions like rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, low back pain, gynecological pain, dental pain, and painful & inflammatory conditions of the ear, nose, and throat. This is a non-steroidal anti-inflammatory drug (NSAID). It should be taken in dose and duration as advice by the doctor. Don't take more than the recommended dose.

• Pain relief

Every medicine has some side effects that typically manage on their own as your body gets used to the medicine, but some people may experience severe side effects rarely. In that case, the patient should contact the doctor immediately.
Some common side effects of Zerodol 100 mg Tablet include:

• Vomiting
• Stomach pain/epigastric pain
• Nausea
• Indigestion
• Diarrhea
• Heartburn
• Loss of appetite

• Doctor determines the exact dose and duration with Zerodol 100 mg Tablet as per the overall health condition of the patient.
• This tablet should be taken with food or after food, but at the fix time every day to get effective results. Don't miss a dose or overdose on the medicine. Swallow it as a whole with a glass of water and do not crush, chew, or open it.
  

• Zerodol 100 mg Tablet is a pain-relieving medicine with Aceclofenac (100mg) and Tizanidine (2mg) as an active ingredient.
• This is a non-steroidal anti-inflammatory drug (NSAID). It acts by inhibiting the secretion of a few chemical messengers that are responsible for pain and inflammation (redness and swelling).
  

• Pareek, A., Chandurkar, N., Chandanwale, A. S., Ambade, R., Gupta, A., & Bartakke, G. (2009). Aceclofenac–tizanidine in the treatment of acute low back pain: a double-blind, double-dummy, randomized, multicentric, comparative study against aceclofenac alone. European Spine Journal, 18(12), 1836-1842. https://pubmed.ncbi.nlm.nih.gov/19421791/
• Zhu, L. L., Wang, Y. H., & Zhou, Q. (2024). Tizanidine: advances in pharmacology & therapeutics and drug formulations. Journal of Pain Research, 1257-1271. https://pubmed.ncbi.nlm.nih.gov/38529017/
• Hardik R, P., & Narajji, C. (2011). Method development and validation for simultaneous estimation of Aceclofenac, Paracetamol and Tizanidine in pharmaceutical dosage form by analytical method (Doctoral dissertation, Acharya & BM Reddy College of Pharmacy (ABMRCP)). http://lrc.acharyainstitutes.in:8080/jspui/handle/123456789/6639
• Borse, S., Ahmad, S., & Tatiya, A. U. (2021). Method Development and Validation for the Simultaneous Estimation of Tizanidine and Aceclofenac by (UHPLC) RP-HPLC in Bulk and Tablet Dosage Forms. Journal of Pharmaceutical Sciences and Research, 13(8), 502-507. https://pharmainfo.in/jpsr/Documents/Volumes/vol13issue08/jpsr13082113.pdf 
• Nenavath, A., & Sreekanth, N. D. S. (2020). A novel RP–HPLC methodology for method development and validation of aceclofenac and tizanidine pharmaceutical dosage forms. Journal of Applied Pharmaceutical Research, 8(4), 33-44. https://media.neliti.com/media/publications/432024-a-novel-rp-hplc-methodology-for-method-d-c208f42c.pdf